BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published bimonthly (6 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2017 Published Issues
5 4 3 2 1
Editors-in-Chief
  • Godefridus J Peters, PhD, Professor, (E-mail:gj.peters@vumc.nl)Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam 1081 HV, Netherlands
Indexing/Abstracting
PubMed, PubMed Central, and Scopus.
Journal Metrics
IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.
ISSN
2218-4333 (online)
Review
Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory 
Ana García-Casas, Dolores C García-Olmo, Damián García-Olmo 
World J Clin Oncol 8(5):378-388. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.378
Minireviews
Stereotactic radiotherapy for prostate cancer: A review and future directions 
Yusef A Syed, Ami K Patel-Yadav, Charlotte Rivers, Anurag K Singh 
World J Clin Oncol 8(5):389-397. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.389
Basic Study
Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia 
Kamini Shah, Bryan F Curtin, Christopher Chu, Daniel Hwang, Mark H Flasar, Erik von Rosenvinge 
World J Clin Oncol 8(5):398-404. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.398
Retrospective Cohort Study
Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp 
Nevena Skroza, Ilaria Proietti, Nicoletta Bernardini, Veronica Balduzzi, Alessandra Mambrin, Anna Marchesiello, Ersilia Tolino, Sara Zuber, Giuseppe La Torre, Concetta Potenza 
World J Clin Oncol 8(5):405-411. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.405
Observational Study
Prophylactic lateral pelvic lymph node dissection in stage IV low rectal cancer 
Hiroshi Tamura, Yoshifumi Shimada, Hitoshi Kameyama, Ryoma Yagi, Yosuke Tajima, Takuma Okamura, Mae Nakano, Masato Nakano, Masayuki Nagahashi, Jun Sakata, Takashi Kobayashi, Shin-ichi Kosugi, Hitoshi Nogami, Satoshi Maruyama, Yasumasa Takii, Toshifumi Wakai 
World J Clin Oncol 8(5):412-419. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.412
Case Report
First report of small cell lung cancer with PTHrP-induced hypercalcemic pancreatitis causing disconnected duct syndrome 
Eric M Montminy, Stephen W Landreneau, Jordan J Karlitz 
World J Clin Oncol 8(5):420-424. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.420
Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer 
Hampig Raphael Kourie, Nicolas Mavroudakis, Philippe Aftimos, Martine Piccart 
World J Clin Oncol 8(5):425-428. Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.425